Combined-modality therapy for unresectable, stage III non-small-cell lung cancer--caveat emptor or caveat venditor?

Johnson, D H

Combined-modality therapy for unresectable, stage III non-small-cell lung cancer--caveat emptor or caveat venditor? [electronic resource] - Journal of the National Cancer Institute Sep 1996 - 1175-7 p. digital

Publication Type: Comment; Editorial

0027-8874

10.1093/jnci/88.17.1175 doi


Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Carcinoma, Small Cell--drug therapy
Dose-Response Relationship, Drug
Follow-Up Studies
Humans
Lung Neoplasms--drug therapy
Neoplasm Staging
Radiotherapy Dosage
Survival Analysis
Treatment Outcome